Ocuphire Pharma Shares Outstanding 2010-2024 | IRD

Ocuphire Pharma shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Ocuphire Pharma Annual Shares Outstanding
(Millions of Shares)
2023 22
2022 21
2021 15
2020 5
2019 3
2018 1
2017 1
2016 0
2015 0
2014 0
2013 0
2012 0
2011 0
2010 0
2009 0
Ocuphire Pharma Quarterly Shares Outstanding
(Millions of Shares)
2024-06-30 26
2024-03-31 25
2023-12-31 22
2023-09-30 22
2023-06-30 21
2023-03-31 21
2022-12-31 21
2022-09-30 20
2022-06-30 20
2022-03-31 19
2021-12-31 15
2021-09-30 17
2021-06-30 14
2021-03-31 11
2020-12-31 5
2020-09-30 4
2020-06-30 4
2020-03-31 4
2019-12-31 3
2019-09-30 1
2019-06-30 1
2019-03-31 1
2018-12-31 1
2018-09-30 1
2018-06-30 1
2018-03-31 1
2017-12-31 1
2017-09-30 1
2017-06-30 1
2017-03-31 0
2016-12-31 0
2016-09-30 0
2016-06-30 0
2016-03-31 0
2015-12-31 0
2015-09-30 0
2015-06-30 0
2015-03-31 0
2014-12-31 0
2014-09-30 0
2014-06-30 0
2014-03-31 0
2013-12-31 0
2013-09-30 0
2013-06-30 0
2013-03-31 0
2012-12-31 0
2012-09-30 0
2012-06-30 0
2012-03-31 0
2011-12-31 0
2011-09-30 0
2011-06-30 0
2011-03-31 0
2010-12-31 0
2010-09-30 0
2010-06-30 0
2010-03-31 0
2009-12-31 0
2009-09-30 0
2009-06-30 0
2009-03-31 0
Sector Industry Market Cap Revenue
$0.000B $0.000B
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00